- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: April 2013
- Public Summary Document (PSD) April 2013 PBAC Meeting - PDF
Rifaximin – April 2013
Rifaximin, tablet, 550 mg, Xifaxan®
Last updated
8 November 2023